<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04442828</url>
  </required_header>
  <id_info>
    <org_study_id>106848</org_study_id>
    <nct_id>NCT04442828</nct_id>
  </id_info>
  <brief_title>3D Echocardiography and Cardiovascular Prognosis in Mitral Regurgitation</brief_title>
  <acronym>3D-PRIME</acronym>
  <official_title>3D Echocardiography and Cardiovascular PRognosis In Mitral REgurgitation (3D-PRIME)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The 3D-PRIME study will analyse whether use of 3D echocardiography can improve risk
      stratification and cardiovascular outcome in patients with mitral regurgitation of different
      etiologies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2020</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major cardiovascular event</measure>
    <time_frame>36 months</time_frame>
    <description>Surgical valve replacement or repair, percutaneous valve intervention, hospitalization due to heart failure, cardiovascular death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death of any cause</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arrhythmic events</measure>
    <time_frame>36 months</time_frame>
    <description>Arrhythmias on 24 hours ECG recordings, Hospitalization due to ECG-documented arrhythmias</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Mitral Regurgitation</condition>
  <arm_group>
    <arm_group_label>Primary mitral regurgitation</arm_group_label>
    <description>Patients with mitral regurgitation due to mitral valve disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Secondary mitral regurgitation</arm_group_label>
    <description>Patients with mitral regurgitation due to ventricular or atrial disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Use of 3D echocardiography in patient follow-up</intervention_name>
    <description>Patients will undergo clinical and echocardiographic examination including detailed 3D echocardiography at study inclusion and at least one follow-up visit.</description>
    <arm_group_label>Primary mitral regurgitation</arm_group_label>
    <arm_group_label>Secondary mitral regurgitation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A cohort of patients with chronic mitral regurgitation referred for clinical and
        echocardiographic assessment at the Heart Valve Clinic at Haukeland University Hospital in
        Bergen, Norway.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adult patients with primary or secondary mitral regurgitation of mild, moderate or severe
        degree, without clinical signs of heart failure and with left ventricular ejection fraction
        â‰¥40%.

        Exclusion Criteria:

        Co-existence of another valve disease of severe degree, clinical signs of heart failure
        combined with ejection fraction &lt;40%, or inability to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stig Urheim, MD PhD</last_name>
    <phone>+4755976755</phone>
    <email>stigur@helse-bergen.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dana Cramariuc, MD PhD</last_name>
      <phone>+4755970534</phone>
      <email>cdan@helse-bergen.no</email>
    </contact>
    <investigator>
      <last_name>Dana Cramariuc, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 19, 2020</study_first_submitted>
  <study_first_submitted_qc>June 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2020</study_first_posted>
  <last_update_submitted>June 19, 2020</last_update_submitted>
  <last_update_submitted_qc>June 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

